Moreover, the expression of CXCL10 is considered an independent prognostic factor for cancer recurrence in CRC [54], while the co-expression of both CXCR3 and CXCL10 in CRC is linked to poorer prognosis and metastatic recurrence [55]. Here, CXCR3 is linked to colorectal carcinoma.